Medical News

RSS

Researchers identify new target for cystic fibrosis

The lab of Kevin Foskett, PhD, the Isaac Ott Professor of Physiology at the University of Pennsylvania School of Medicine, has found a possible new target for fighting cystic fibrosis (CF) that could compensate for the lack of a functioning ion channel in affected CF-related cells. Their finding appears in the Journal of Clinical Investigation.

18 Sep 2010

Research Roundup: Assessing physician quality; Community health centers' future; Why doctors take gifts; Access to HIV treatment

Archives of Internal Medicine: Associations Between Physician Characteristics And Quality Of Care - Since "most patients do not have access to physician quality measures," they are often encouraged to use public information such as malpractice claims and board certification status to chose a doctor, according to this report that used 2004-2005 insurance claims from about 10,000 Massachusetts physicians for more than 1.13 million adults.

18 Sep 2010

FDA accepts to review Aricept NDA for Alzheimer's disease

Teikoku Pharma USA, Inc., an international specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for a new weekly transdermal patch of Aricept, a leading medication for the treatment of Alzheimer's disease.

18 Sep 2010

FDA reviews Actos drug for bladder cancer risk

The U.S. Food and Drug Administration today announced it has begun a safety review of the diabetes drug Actos (pioglitazone), after receiving preliminary results from a long-term observational study designed to evaluate the risk of bladder cancer associated with use of this drug.

18 Sep 2010

Elixir Medical commences enrollment in EXCELLA BD trial for DESyne BD Novolimus Eluting CSS

Elixir Medical Corporation, a developer of product platforms that combine innovative medical devices with potent pharmaceuticals for site-specific therapies, announced the initiation of patient enrollment in the EXCELLA BD Randomized Clinical Trial designed to evaluate Elixir's next generation Novolimus Eluting Coronary Stent System (CSS) with bioabsorbable coating, the Elixir DESyne BD Novolimus Eluting CSS.

18 Sep 2010

Researchers discover evolutionary nature of bacteria to spread chronic infectious disease

Researchers from the Center for Genomic Sciences at Allegheny General Hospital (AGH) in Pittsburgh have made a landmark discovery about the evolutionary nature of bacteria in the setting of chronic infectious disease. Reporting today in the journal PLos Pathogens, the AGH team documents for the first time that bacteria engage in a process called horizontal gene transfer to evolve rapidly during the course of a single infection.

18 Sep 2010

BARDA awards contract to Emergent BioSolutions for anthrax vaccine development

The U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) awarded a $51 million contract to Emergent BioSolutions, Inc., of Rockville, Md., for the development of a new anthrax vaccine using the protective antigen (rPA) to stimulate a protective immune response that neutralizes the anthrax toxins.

18 Sep 2010

Boehringer Ingelheim commences afatinib Phase III clinical trial in advanced breast cancer

Boehringer Ingelheim today announced the initiation of a phase III clinical trial to investigate one of its most advanced oncology pipeline compounds, afatinib, for the treatment of patients with advanced (metastatic) breast cancer. Afatinib is an oral compound (taken as a tablet), which is a next generation, targeted therapy, that irreversibly inhibits both, the epidermal growth factor receptor (EGFR/HER1) and the human epidermal receptor HER2, which are involved in tumour growth and spread.

18 Sep 2010

FDA decides to review information on Avastin for advanced HER2-negative breast cancer

Genentech, Inc., a member of the Roche Group, today announced that information submitted by the company to the U.S. Food and Drug Administration (FDA) during the review of the supplemental Biologics License Applications (sBLAs) for Avastin (bevacizumab) for previously untreated (first-line) advanced HER2-negative breast cancer has been deemed a major amendment.

18 Sep 2010

Accuray Incorporated showcases CyberKnife VSI System at ESTRO Annual Congress

Accuray Incorporated, a global leader in the field of radiosurgery, announced today that for the first time in Europe the company showcased its latest offering, the CyberKnife VSI System, at ESTRO 29, the Annual Congress of the European Society for Therapeutic Radiology and Oncology in Barcelona, Spain.

18 Sep 2010

Today's Opinions: Recession's impact on the uninsured; Repeal of health reform? Then what?

The record number of people last year without health insurance — 50.7 million, up from 46.3 million in 2008 — provides stark evidence of why the country desperately needs the health care reforms enacted in March (9/16).

18 Sep 2010

Solatube discusses green lighting at FMA Congress

Imagine a building in which sunlight could be captured and utilized in the most unexpected and never-before-seen places. Imagine the "World's First Green Olympics." Imagine employees who are happier, more productive, healthier and less prone to accidents. All are reality, thanks to Solatube International's tubular Daylighting Devices, which use state-of-the-art design to provide superior performance and efficiency to every daylighting application imaginable.

17 Sep 2010

Conference to discuss frontline of immunological research, its clinical application

The immune system is evolved to protect our body against a variety of infectious agents which can cause serious and often fatal diseases. We now appreciate that the immune system is also involved in surveillance of malignant transformation of normal cells that constitute our body, as well as rejection of transplanted organs.

17 Sep 2010

Cell Therapeutics announces results from Annual Meeting

Cell Therapeutics, Inc. announced today the results from its Annual Meeting of Shareholders held on Thursday, September 16, 2010.

17 Sep 2010

BRAVADA expands Women's Athletica stores

BRAVADA International announced today expansion plans of its BRAVADA Women's Athletica stores through high traffic commercial shopping malls across North America.

17 Sep 2010

Aradigm to present Phase 1 studies of inhaled liposomal ciprofloxacin at 2010 ERS Congress

Aradigm Corporation today announced it is presenting data on September 22, 2010, from its Phase 1 studies at the ERS Annual Congress in Barcelona, Spain. The podium presentation elaborates on the pharmacokinetic parameters of ciprofloxacin in the blood and sputum samples that were observed in the healthy volunteers and non-cystic fibrosis bronchiectasis (BE) patients.

17 Sep 2010

Teenagers devote more time to sedentary behaviour at weekend: European study

The new school year has started and the school routine is back. A European study led by Spanish researchers has shown how the proportion of young people who watch television and play on the computer for more than two hours per day doubles at the weekend. And while boys opt for video games, teenage girls prefer to surf the net.

17 Sep 2010

Emerging Vision reports 402% increase in operating income for first half 2010

Emerging Vision, Inc. today recapped its results for the six months ended June 30, 2010.

17 Sep 2010

Nemours wins HIMSS Davies Organizational Award of Excellence

Healthcare Information and Management Systems Society (HIMSS) announced that Nemours, a premiere healthcare system for children operating in Delaware, Pennsylvania, New Jersey and Florida, is a 2010 recipient of its prestigious HIMSS Davies Organizational Award of Excellence.

17 Sep 2010

First Edition: September 17, 2010

"In a reflection of the battered economy, the number of people without health insurance rose sharply last year to 50.7 million — an all time high — according to data released Thursday by the Census Bureau" (Kaiser Health News). KHN also provides related resources, including a Census Bureau summary of key findings, the chapter on health insurance coverage and access the full report, "Income, Poverty, and Health Insurance Coverage in the United States: 2009."

17 Sep 2010

Medical News

Researchers identify new target for cystic fibrosis

Research Roundup: Assessing physician quality; Community health centers' future; Why doctors take gifts; Access to HIV treatment

FDA accepts to review Aricept NDA for Alzheimer's disease

FDA reviews Actos drug for bladder cancer risk

Elixir Medical commences enrollment in EXCELLA BD trial for DESyne BD Novolimus Eluting CSS

Researchers discover evolutionary nature of bacteria to spread chronic infectious disease

BARDA awards contract to Emergent BioSolutions for anthrax vaccine development

Boehringer Ingelheim commences afatinib Phase III clinical trial in advanced breast cancer

FDA decides to review information on Avastin for advanced HER2-negative breast cancer

Accuray Incorporated showcases CyberKnife VSI System at ESTRO Annual Congress

Today's Opinions: Recession's impact on the uninsured; Repeal of health reform? Then what?

Solatube discusses green lighting at FMA Congress

Conference to discuss frontline of immunological research, its clinical application

Cell Therapeutics announces results from Annual Meeting

BRAVADA expands Women's Athletica stores

Aradigm to present Phase 1 studies of inhaled liposomal ciprofloxacin at 2010 ERS Congress

Teenagers devote more time to sedentary behaviour at weekend: European study

Emerging Vision reports 402% increase in operating income for first half 2010

Nemours wins HIMSS Davies Organizational Award of Excellence

First Edition: September 17, 2010

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News